Ahlering, Beth - ESRC Centre for Business Research - 2004
Cross-national regulatory differences in safety, price and intellectual property protection are an inherent feature of … the operating environment of the global pharmaceutical firm. Institutional, transaction cost and more recent ‘race to the … investment in stringently regulated markets. However, a cross-national empirical study of the FDI levels of 20 firms across 19 …